Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 133

Sanofi sends Enable Injections part way to $50m

The drug injection device developer has reached the first close of a $50m round, with Sanofi leading the tranche and Cincinnati Children’s Hospital and Cleveland Clinic also investing.

Oct 26, 2018

100 Thieves takes funding haul to $25m

Media holding company WndrCo is among the investors in a series A round that helped eSports and lifestyle brand 100 Thieves take its total funding to $25m.

Oct 25, 2018

ASAP engineers ZF Friedrichshafen deal

ZF Friedrichshafen has paid an undisclosed sum for a stake in engineering services provider ASAP Holding sized at over 35%.

Oct 24, 2018

Microbiotica digests $5.2m investment

Seventure Partners has injected $5.2m into the Sanger Institute spinout, which has now raised $15.2m from investors also including IP Group and Cambridge Innovation Capital.

Oct 24, 2018

Corporates hit Click in $19m round

Drug developers Sanofi and Hikma both contributed to a funding round for health management app developer Click Therapeutics to bring its total financing to more than $26m.

Oct 22, 2018

Corporate venturing deal net: 15-19 October 2018

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Oct 19, 2018

RapidAim hits funding target

The Csiro Innovation Fund has invested $890,000 in RapidAim, co-founded by three Csiro researchers, to support a trial of a fruit fly monitoring system.

Oct 19, 2018

Corporates drive Momenta to $1bn valuation

Tencent and existing backer Nio Capital both invested as autonomous driving software developer Momenta took its overall funding to $200m.

Oct 19, 2018

Oh My Green tosses together $20m

Stanford-Start X Fund has put its weight behind Oh My Green's seed round, which also attracted a host of venture capital firms.

Oct 18, 2018

Amgen inserts $66m into Oxford Nanopore

Oxford Nanopore has secured $66m from Amgen, after the latter’s subsidiary Decode Genetics used the spinout’s technology to sequence hundreds of human genomes.

Oct 18, 2018
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here